Hepatitis C Virus Testing Market: By Technique (Polymerase Chain Reaction Tests, Immunoassays, Others), By Test (Hepatitis C Antibody Test, Hepatitis C RNA Quantitative Test, Hepatitis C RNA Qualitative Test, Hepatitis C RIBA, Hepatitis C Genotype, Viral Load),  By End-user (Hospitals, Diagnostic Centres, Blood Donation Centres) and Geography   

Purchase Option

$ 4400
$ 6600
$ 8900

Hepatitis C Virus Testing market size was valued at USD x billion in 2022 and is expected to grow at a CAGR of x% from 2023-2029. Hepatitis C is an infection caused by the Hepatitis C virus that disseminates through contaminated blood from an infected person. It can spread in a number of ways, including unprotected sex, tattooing, sharing contaminated needles, other injecting equipment, contaminated blood transfusions, and organ transplants. As per WHO, in 2022, 58 million people have chronic hepatitis C virus infection, with about 1.5 million new infections occurring per year. The Hepatitis C test is preliminary that helps in the detection of antibodies to the hepatitis C virus. The screening and testing of chronic hepatitis C infection also led to the evaluation and proper treatment against liver disease, cirrhosis, hepatocellular carcinoma, and associated morbidity and mortality. The compulsion of screening blood before blood donation, transfusion, and organ donation is expected to fuel the demand for the hepatitis-C virus testing market.

According to WHO 2023, about 118.54 million blood donations are collected worldwide increasing the market for hepatitis C tests. The advancement in immunoassays and Polymerase Chain reaction (PCR) techniques for the detection have raised the opportunities for market development. Based on the type of test, Hepatitis C antibody tests are currently dominating the market as they are cost-effective, tolerable, sensitive, and provide results quickly. The development of rapid Self-testing Hepatitis C virus (HCVST) is becoming tremendously popular and causing a surge in the market. For instance, Atomo Diagnostics announced the launch of a rapid diagnostic test for screening the Hepatitis C virus in 2019. However several clinical laboratories are still in the developing stages, with a major restrain in having skilled technicians to ensure efficient sample collection, storage, transportation, and handling of Next Generation Sequencing (NGS) and lab-on-a-chip PCR machines leading to a decline in the market. Moreover, the cost of a few diagnostic tests is very high and it hampers the growth of the market. However, the adoption of the “Global health sector strategy on viral Hepatitis” by the World Health Assembly with the proposed goal to eliminate viral hepatitis as a public threat by 2030 has led to more awareness among people and thus further increase the market. The increasing awareness among people, emerging key market players, initiatives taken by government bodies, expanding molecular diagnostics technology, and expansion in the biotechnology and biopharmaceutical industries are likely to present significant growth prospects in the forecasted years.

Hepatitis C Virus Testing Market Key Developments:
  • In April 2023, Beckman Coulter acquired licensed rights to testing for hepatitis C virus (HCV) from Siemens Healthcare Diagnostics to develop, manufacture, and sell quantitative viral load HCV blood tests for use on the company's molecular diagnostic instrument.
  • In September 2022, J Mitra launched the 4th Gen Elisa-based HCV test– the HCV Gen 4 Ag & Ab Microlisa. It is an in-vitro qualitative enzyme-linked immunosorbent assay for detecting HCV core antigens and antibodies against HCV (anti-HCVs) in human serum or plasma.

Global Hepatitis C Virus Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

x%

Largest Market

Europe

Fastest Growing Market

North America
Hepatitis C Virus Testing Market Dynamics

Increase in hepatitis C virus testing market is mainly attributed to high incidence of chronic infection with hepatitis C virus. Furthermore, unhygienic blood donation practices are the considerable cause of spread of hepatitis C virus. Hepatitis C screening test is compulsory before the organ donation, increase in organ donation globally expected to boost the testing market growth. The increase in healthcare expenditure, changing lifestyle and increase in government initiatives are some of the key factors driving the growth of global hepatitis C virus antiviral Testing Market. In addition, growing healthcare awareness about the hepatitis C virus is also fueling the growth of global hepatitis C virus testing market. However, stringent regulation for approval of hepatitis C testing is the major factor expected to hamper the hepatitis C virus testing market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Hepatitis C Virus Testing Market Segmentation

By Technique
  • Polymerase Chain Reaction Tests
  • Immunoassays
  • Others
By Test
  • Hepatitis C Antibody Test
  • Hepatitis C RNA Quantitative Test
  • Hepatitis C RNA Qualitative Test
  • Hepatitis C RIBA
  • Hepatitis C Genotype
  • Viral Load
By End-user
  • Hospitals
  • Diagnostic Centres
  • Blood Donation Centres
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The hepatitis c virus testing market size was valued at USD x million in 2022

The hepatitis c virus testing market key players are: Abbott Laboratories (U.S.) Bio Rad Laboratories Inc. (U.S.) Qiagen (Germany) Bayer AG (Switzerland) OraSure Technologies (U.S.) Siemens Healthcare GmbH (Germany) BioGenex (U.S.) H. Hoffman-La Roche Ltd (Switzerland) Thermo Fisher Scientific Inc. (U.S.) Ortho Clinical Diagnostic Inc. (U.S.)

The hepatitis c virus testing market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive Summary
2. Global Hepatitis C Virus Testing Market Introduction 
2.1. Global Hepatitis C Virus Testing Market  - Taxonomy
2.2. Global Hepatitis C Virus Testing Market  - Definitions
2.2.1. Technique
2.2.2. Test
2.2.3. End-User
2.2.4. By Region
3. Global Hepatitis C Virus Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
3.8. USP
3.9. Macro Trends
3.10. Epidemiology
4. Global Hepatitis C Virus Testing Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Hepatitis C Virus Testing Market  By Technique, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Polymerase Chain Reaction Tests
5.1.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Immunoassays
5.2.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Hepatitis C Virus Testing Market  By Test, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Hepatitis C Antibody Test
6.1.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Hepatitis C RNA Quantitative Test
6.2.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Hepatitis C RNA Qualitative Test
6.3.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Hepatitis C RIBA
6.4.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Hepatitis C Genotype
6.5.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Viral Load
6.6.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7. Global Hepatitis C Virus Testing Market  By End-User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostic Centres
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Blood Donation Centres
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.Global Hepatitis C Virus Testing Market  By By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Latin America
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Middle East and Africa (MEA)
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6.  Global Hepatitis C Virus Testing Market - Opportunity Analysis Index, By Test, Technique, End-User and By Region, 2023-2029
8. North America Hepatitis C Virus Testing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Technique Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1. Polymerase Chain Reaction Tests
8.1.2. Immunoassays
8.1.3. Others
8.2. Test Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1. Hepatitis C Antibody Test
8.2.2. Hepatitis C RNA Quantitative Test
8.2.3. Hepatitis C RNA Qualitative Test
8.2.4. Hepatitis C RIBA
8.2.5. Hepatitis C Genotype
8.2.6. Viral Load
8.3. End-User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1. Hospitals
8.3.2. Diagnostic Centres
8.3.3. Blood Donation Centres
8.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.4.1. United States of America (USA)
8.4.2. Canada
9. Europe Hepatitis C Virus Testing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Technique Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1. Polymerase Chain Reaction Tests
9.1.2. Immunoassays
9.1.3. Others
9.2. Test Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1. Hepatitis C Antibody Test
9.2.2. Hepatitis C RNA Quantitative Test
9.2.3. Hepatitis C RNA Qualitative Test
9.2.4. Hepatitis C RIBA
9.2.5. Hepatitis C Genotype
9.2.6. Viral Load
9.3. End-User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1. Hospitals
9.3.2. Diagnostic Centres
9.3.3. Blood Donation Centres
9.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1. Germany
9.4.2. France
9.4.3. Italy
9.4.4. United Kingdom (UK)
9.4.5. Spain
9.4.6. Rest of EU
10. Asia Pacific (APAC) Hepatitis C Virus Testing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Technique Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1. Polymerase Chain Reaction Tests
10.1.2. Immunoassays
10.1.3. Others
10.2. Test Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1. Hepatitis C Antibody Test
10.2.2. Hepatitis C RNA Quantitative Test
10.2.3. Hepatitis C RNA Qualitative Test
10.2.4. Hepatitis C RIBA
10.2.5. Hepatitis C Genotype
10.2.6. Viral Load
10.3. End-User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1. Hospitals
10.3.2. Diagnostic Centres
10.3.3. Blood Donation Centres
10.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1. China
10.4.2. India
10.4.3. Australia and New Zealand (ANZ)
10.4.4. Japan
10.4.5. Rest of APAC
11. Latin America Hepatitis C Virus Testing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Technique Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1. Polymerase Chain Reaction Tests
11.1.2. Immunoassays
11.1.3. Others
11.2. Test Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1. Hepatitis C Antibody Test
11.2.2. Hepatitis C RNA Quantitative Test
11.2.3. Hepatitis C RNA Qualitative Test
11.2.4. Hepatitis C RIBA
11.2.5. Hepatitis C Genotype
11.2.6. Viral Load
11.3. End-User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1. Hospitals
11.3.2. Diagnostic Centres
11.3.3. Blood Donation Centres
11.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of LA
12. Middle East and Africa (MEA) Hepatitis C Virus Testing Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Technique Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1. Polymerase Chain Reaction Tests
12.1.2. Immunoassays
12.1.3. Others
12.2. Test Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1. Hepatitis C Antibody Test
12.2.2. Hepatitis C RNA Quantitative Test
12.2.3. Hepatitis C RNA Qualitative Test
12.2.4. Hepatitis C RIBA
12.2.5. Hepatitis C Genotype
12.2.6. Viral Load
12.3. End-User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1. Hospitals
12.3.2. Diagnostic Centres
12.3.3. Blood Donation Centres
12.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of MEA
13.  Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Abbott Laboratories (U.S.)
13.2.2. Bio Rad Laboratories Inc. (U.S.)
13.2.3. Qiagen (Germany)
13.2.4. Bayer AG (Switzerland)
13.2.5. OraSure Technologies (U.S.)
13.2.6. Siemens Healthcare GmbH (Germany)
13.2.7. BioGenex (U.S.)
13.2.8. H. Hoffman-La Roche Ltd (Switzerland)
13.2.9. Thermo Fisher Scientific Inc. (U.S.)
13.2.10. Ortho Clinical Diagnostic Inc. (U.S.)
14.  Research Methodology
15.  Key Assumptions and Acronyms
  • Abbott Laboratories (U.S.)
  • Bio Rad Laboratories Inc. (U.S.)
  • Qiagen (Germany)
  • Bayer AG (Switzerland)
  • OraSure Technologies (U.S.)
  • Siemens Healthcare GmbH (Germany)
  • BioGenex (U.S.)
  • H. Hoffman-La Roche Ltd (Switzerland)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Ortho Clinical Diagnostic Inc. (U.S.)

Adjacent Markets